Mackay Shields LLC’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-140,623
Closed -$6.7M 405
2022
Q1
$6.7M Sell
140,623
-64,051
-31% -$2.71M 0.06% 290
2021
Q4
$8.43M Sell
204,674
-4,649
-2% -$175K 0.07% 257
2021
Q3
$7.22M Sell
209,323
-6,062
-3% -$207K 0.07% 257
2021
Q2
$6.81M Sell
215,385
-31,830
-13% -$1.02M 0.06% 268
2021
Q1
$7.71M Sell
247,215
-20,738
-8% -$623K 0.06% 356
2020
Q4
$8.07M Sell
267,953
-1,269
-0.5% -$37.5K 0.06% 357
2020
Q3
$6.87M Buy
269,222
+15,184
+6% +$403K 0.05% 390
2020
Q2
$6.58M Sell
254,038
-1,153
-0.5% -$30.6K 0.05% 367
2020
Q1
$6.7M Buy
255,191
+453
+0.2% +$14.2K 0.06% 332
2019
Q4
$8.28M Sell
254,738
-112,078
-31% -$3.63M 0.06% 369
2019
Q3
$12.6M Sell
366,816
-254,480
-41% -$8.54M 0.08% 297
2019
Q2
$21.2M Sell
621,296
-79,707
-11% -$2.81M 0.14% 156
2019
Q1
$25.1M Buy
701,003
+93,411
+15% +$3.18M 0.18% 123
2018
Q4
$19.5M Sell
607,592
-137,745
-18% -$4.41M 0.16% 157
2018
Q3
$23.2M Buy
745,337
+132,231
+22% +$4.07M 0.18% 159
2018
Q2
$18.6M Buy
613,106
+253,047
+70% +$7.24M 0.13% 204
2018
Q1
$10M Buy
+360,059
New +$9.72M 0.06% 348

Other funds holding EXC

Mackay Shields LLC's EXC Position: Q2 2022 in Review

Mackay Shields LLC sold out of Exelon (EXC) in Q2 2022, closing a stake of 140,623 shares — an estimated $6.7M sold.

Mackay Shields LLC first reported a position in EXC in Q1 2018 and held it in 17 quarters. The position peaked at $25.1M in Q1 2019. 1,018 funds tracked by Wall St. Rank hold EXC as of Q2 2022.

  • Mackay Shields LLC reported no remaining Exelon position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 140,623 Exelon shares in Q2 2022, an estimated $6.7M.
  • Mackay Shields LLC first reported a position in Exelon in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Exelon position peaked at $25.1M in Q1 2019.
  • 1,018 funds tracked by Wall St. Rank held Exelon as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.